Molecular Informatics
Scope & Guideline
Unlocking Insights Through Molecular Modeling
Introduction
Aims and Scopes
- Computational Drug Discovery:
The journal extensively covers methodologies related to the computational identification and optimization of drug candidates, including virtual screening, molecular docking, and pharmacophore modeling. - Cheminformatics and Data Science:
Research in this area focuses on the application of data science techniques to chemical data, including the development of predictive models using machine learning and statistical methods. - Molecular Modeling and Simulation:
The journal publishes studies employing molecular dynamics simulations, quantum chemical calculations, and other modeling techniques to understand molecular interactions and dynamics. - Toxicology and ADMET Studies:
There is a strong emphasis on the prediction of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties of compounds, which is crucial for drug development. - Natural Product Informatics:
Research highlighting the role of natural products in drug discovery and their computational analysis is a significant aspect, including the exploration of chemical space related to natural compounds.
Trending and Emerging
- Machine Learning and AI Applications:
There is a significant rise in the use of artificial intelligence and machine learning techniques for predictive modeling, data analysis, and drug discovery processes, showcasing the integration of advanced computational methods. - Integrated Approaches for Drug Repurposing:
Emerging studies are increasingly focusing on drug repurposing strategies, utilizing network-based approaches and computational tools to identify new uses for existing drugs, particularly in response to global health challenges. - Interdisciplinary Research:
Research that combines insights from various fields such as bioinformatics, chemoinformatics, and systems biology is gaining traction, promoting a holistic view of molecular interactions and drug development. - Natural Product-Based Drug Discovery:
There is a resurgence of interest in natural products, with studies exploring their potential as sources for new drug candidates through computational methodologies, reflecting a trend towards sustainable and bio-inspired drug design.
Declining or Waning
- Traditional QSAR Models:
While quantitative structure-activity relationship (QSAR) models remain important, there is a noticeable decline in traditional approaches, with a shift towards more advanced machine learning techniques that enhance predictive capabilities. - Basic Molecular Docking Studies:
Research focused solely on molecular docking without integration of other computational methods (like dynamics simulations or machine learning) is becoming less frequent, as more comprehensive approaches are favored. - Single-Target Drug Discovery:
The trend is moving towards multi-target and polypharmacology strategies, leading to a decrease in studies that focus exclusively on single-target drug discovery approaches.
Similar Journals
Peptide Science
Pioneering advancements in biochemistry and biophysics.Peptide Science, published by Wiley, is an esteemed journal dedicated to advancing the understanding of peptide chemistry and its applications across various scientific disciplines, including biochemistry, biophysics, and organic chemistry. Since its inception in 2018 and continuing through 2024, this journal has provided an essential platform for the dissemination of innovative research, engaging articles, and critical reviews. With an impressive Q3 ranking in the fields of Biochemistry and Biomaterials, and a Q2 status in Biophysics and Organic Chemistry as of 2023, Peptide Science acknowledges its integral role in addressing significant scientific challenges. This open-access journal ensures that findings are readily available to a global audience, fostering collaboration and knowledge sharing among researchers, professionals, and students alike. The journal exemplifies excellence in scholarly communication, making it an essential resource for anyone interested in the intricate world of peptide research.
COMPUTERS IN BIOLOGY AND MEDICINE
Innovating Solutions at the Intersection of Biology and MedicineCOMPUTERS IN BIOLOGY AND MEDICINE is a prestigious academic journal published by Pergamon-Elsevier Science Ltd, dedicated to advancing the fields of Computer Science Applications and Health Informatics. With an impressive impact factor and ranking within the Q1 quartile for both categories, this journal plays a crucial role in disseminating high-quality research findings that influence cutting-edge developments at the intersection of computing and healthcare. Covering a broad range of topics from computational biology to medical informatics, it serves as a vital resource for researchers, professionals, and students striving to harness technology for medical advancements. The journal has been publishing since 1970 and continues to evolve, incorporating the latest trends and innovations in the field, thereby ensuring that it remains a key contributor to scientific inquiry and knowledge. With accessible content and a global reach, COMPUTERS IN BIOLOGY AND MEDICINE invites submissions that elevate the understanding and application of computational methods in biological and medical contexts.
Current Computer-Aided Drug Design
Fostering Collaboration for Breakthroughs in Drug DiscoveryCurrent Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.
MOLECULAR DIVERSITY
Connecting Chemistry, Biology, and Pharmacology for a Better TomorrowMOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.
Journal of Chemical Theory and Computation
Bridging Chemistry and Computer Science for Tomorrow's InnovationsThe Journal of Chemical Theory and Computation, published by the American Chemical Society, stands at the forefront of the multidisciplinary fields of computational chemistry and computer science applications. With an impressive impact factor and ranking in the top quartile (Q1) in both Physical and Theoretical Chemistry and Computer Science Applications, this journal serves as a vital platform for researchers and professionals seeking to publish cutting-edge research on computational methodologies and innovative theoretical approaches. Spanning from 2005 to 2024, the journal aims to disseminate high-quality studies that advance understanding of molecular systems and the development of computational techniques. Its esteemed reputation is reflected in its robust metrics, ranking #23 in Physical and Theoretical Chemistry and #101 in Computer Science Applications by Scopus, showcasing its significant influence in the academic community. While it does not currently offer open access, the journal remains accessible to a wide audience, making it an essential resource for those engaged in the evolving landscape of chemical theory and computation.
COMPUTATIONAL BIOLOGY AND CHEMISTRY
Empowering Researchers to Navigate the Frontiers of Computational Biology and ChemistryCOMPUTATIONAL BIOLOGY AND CHEMISTRY is a distinguished academic journal published by Elsevier Science Ltd, focusing on the dynamic intersection of computational biology, biochemistry, and chemistry. With an ISSN of 1476-9271 and an E-ISSN of 1476-928X, this journal is committed to disseminating high-quality research that employs computational techniques to solve complex biological and chemical problems. As of 2023, the journal holds a substantial impact factor reflecting its significance and rigorous peer-review process, categorized in the Q2 quartile for both Computational Mathematics and Organic Chemistry, alongside Q3 classifications in Biochemistry and Structural Biology. With a continuous publication history spanning from 2003 to 2024, it serves as a critical resource for researchers, professionals, and students alike. The journal offers various open access options, ensuring that vital research findings are accessible to a global audience, further enhancing collaboration across disciplines. Engage with cutting-edge studies and contribute to the evolving landscape of computational methodologies in the life sciences through this esteemed publication.
MOLECULAR SIMULATION
Exploring the intricate world of molecular systems.MOLECULAR SIMULATION, published by TAYLOR & FRANCIS LTD, stands as a pivotal platform in the interdisciplinary landscape of molecular modeling and simulation, bridging the fields of chemistry, physics, and materials science. Since its inception in 1987, this journal has been dedicated to publishing high-quality research that advances the understanding of complex molecular systems. With a variety of articles covering innovative computational methods and their applications across diverse domains, it resonates well with both established researchers and emerging scholars. Although currently not an open access journal, it maintains a respectable presence within the academic community, illustrated by its Q3 quartile rankings in key categories such as Chemical Engineering, Condensed Matter Physics, and Information Systems as of 2023. Further, its Scopus rankings position it favorably within the respective fields, making it an essential resource for anyone interested in the quantitative aspects of molecular research. With its comprehensive scope, MOLECULAR SIMULATION continues to foster collaboration and innovation, helping to bridge theoretical research with practical applications.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
Pioneering New Frontiers in Molecular Design and ScreeningJOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, published by Springer, serves as a premier platform for researchers in the fields of computer science applications, drug discovery, and physical and theoretical chemistry. Since its inception in 1987, the journal has played a pivotal role in advancing the methodologies and technologies used in molecular design and screening. With an impressive impact factor and a ranking within the top quartile across related disciplines, this journal offers invaluable insights and innovative approaches that are essential for scholars and practitioners in these dynamic fields. The journal's rigorous peer-review process ensures high-quality publications that contribute significantly to both theoretical and practical advancements. Though it operates under a subscription model, the journal remains dedicated to fostering knowledge dissemination and collaboration among researchers.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING
Unraveling Complexities with Advanced Graphical ModelsJOURNAL OF MOLECULAR GRAPHICS & MODELLING, published by Elsevier Science Inc, is a leading peer-reviewed journal dedicated to the fields of molecular graphics and modeling. With an ISSN of 1093-3263 and an E-ISSN of 1873-4243, this journal has established its relevance since its inception in 1997, and continues to thrive as it extends its scope into 2024. Acknowledged for its impact in the academic community, it holds a Q2 ranking in both Computer Graphics and Computer-Aided Design and Materials Chemistry, as well as a Q3 ranking in Physical and Theoretical Chemistry and Spectroscopy, reflecting its significance across multidisciplinary research domains. Notably, the journal ranks in the 73rd percentile for Computer Graphics and maintains competitive standings in Materials Science and Chemistry areas. Although it does not currently offer open access options, the journal is an essential resource for researchers, professionals, and students who are engaged in cutting-edge studies and applications in molecular graphics, computational methods, and material design. By facilitating a deeper understanding of molecular interactions through innovative graphical modeling, the journal contributes significantly to advancements in science and technology.
SAR AND QSAR IN ENVIRONMENTAL RESEARCH
Pioneering the Path from Structure to Environmental Impact.SAR and QSAR in Environmental Research is a leading journal published by Taylor & Francis Ltd, focusing on the integration of Structure-Activity Relationships (SAR) and Quantitative Structure-Activity Relationships (QSAR) within the realm of environmental science. Since its inception in 1993, the journal has been a pivotal platform for disseminating innovative research that bridges the gap between chemistry and environmental sustainability, ranking in the Q3 quartile for Bioengineering, Drug Discovery, and miscellaneous Medicine categories as of 2023. Featuring a compelling collection of peer-reviewed articles, it caters to academic and professional audiences seeking to enhance their understanding of molecular interactions and their implications for environmental health. Although the journal does not currently offer Open Access options, its rigorous editorial standards ensure high-quality, impactful publications that are crucial for advancing methodologies in pharmacology, toxicology, and bioengineering. With an ISSN of 1062-936X and an E-ISSN of 1029-046X, SAR and QSAR in Environmental Research continues to serve as an essential resource for researchers, academics, and practitioners dedicated to innovative approaches in environmental research.